TrialInternational journal of hematology2019

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Shin-Ichi Fuchida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.